Appili Therapeutics Inc. (TSE:APL – Get Rating) – Analysts at Zacks Small Cap increased their FY2023 earnings per share (EPS) estimates for shares of Appili Therapeutics in a research note issued to investors on Tuesday, February 21st. Zacks Small Cap analyst D. Bautz now expects that the company will earn ($0.08) per share for the year, up from their previous forecast of ($0.09).
Get Appili Therapeutics alerts:Appili Therapeutics (TSE:APL – Get Rating) last posted its quarterly earnings results on Tuesday, February 14th. The company reported C($0.02) earnings per share for the quarter, hitting the consensus estimate of C($0.02). The business had revenue of C$0.01 million during the quarter.
Appili Therapeutics Price Performance
Read More
- Carvana Skidding On Revenue Decrease, Heavy Debt Burden
- What Are Consumer Staples Stocks?
- Is Rocky Brands Dividend A Good Fit For Your Portfolio?
- Beyond Meat Stock Is Not Beyond Hope
- Analysts Holding As Pfizer Waits On Two Phase 3 Studies
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.